Gaucher disease in the COVID-19 pandemic environment: The good, the bad and the unknown
Ginns, Edward I. Ryan, Emory Sidransky, Ellen
Ginns, Edward I.
Ryan, Emory
Sidransky, Ellen
Citations
Altmetric:
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Journal Article
Publication Date
2021-04-01
Subject Area
Collections
Embargo Expiration Date
Link to Full Text
Abstract
Early in the course of the novel coronavirus disease 2019 (COVID-19) pandemic, the rare disease community anticipated that patients with lysosomal and other metabolic disorders would be at increased risk for poor disease outcomes and mortality from the SARS-CoV-2 virus.
Source
Ginns EI, Ryan E, Sidransky E. Gaucher disease in the COVID-19 pandemic environment: The good, the bad and the unknown. Mol Genet Metab. 2021 Apr;132(4):213-214. doi: 10.1016/j.ymgme.2021.02.005. Epub 2021 Feb 24. PMID: 33676819; PMCID: PMC7903902. Link to article on publisher's site
Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1016/j.ymgme.2021.02.005
Permanent Link to this Item
PubMed ID
33676819